Aquestive Therapeutics In... (AQST)
NASDAQ: AQST
· Real-Time Price · USD
4.12
0.01 (0.24%)
At close: Aug 15, 2025, 12:51 PM
Aquestive Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 10M | 8.72M | 11.87M | 13.54M | 20.1M | 12.05M | 13.21M | 13M | 13.24M | 11.13M | 10.68M | 11.46M | 13.27M | 12.27M | 11.08M | 13.29M | 15.35M | 11.12M |
Cost of Revenue | 4.56M | 3.65M | 4.52M | 4.44M | 4.53M | 4.39M | 4.68M | 4.8M | 6.62M | 4.74M | 5.3M | 4.63M | 5.24M | 4.21M | 3.37M | 4.4M | 4.47M | 2.76M |
Gross Profit | 5.44M | 5.07M | 7.35M | 9.11M | 15.57M | 7.66M | 8.53M | 8.2M | 6.62M | 6.4M | 5.38M | 6.84M | 8.02M | 8.06M | 7.71M | 8.89M | 10.88M | 8.37M |
Operating Income | -11.37M | -19.36M | -13.58M | -8.29M | 55K | -8.96M | -3.91M | -2.38M | -4.21M | 9.58M | -10.71M | -8.85M | -12.76M | -9.74M | -11.67M | -7.97M | -6.52M | -8.53M |
Interest Income | 2.1M | 713K | 734K | 979K | 1.4M | 329K | 165K | 1.51M | 129K | 14.51M | 65K | 5K | 32K | n/a | 135K | n/a | 373K | n/a |
Pretax Income | -13.55M | -22.93M | -17.07M | -11.51M | -2.75M | -12.83M | -8.01M | -2.17M | -5.51M | 8.07M | -12.35M | -12.54M | -16.3M | -13.22M | -28.95M | -14.55M | -12.37M | -14.67M |
Net Income | -13.55M | -22.93M | -17.05M | -11.51M | -2.75M | -12.83M | -8.11M | -2.04M | -5.79M | 19.31M | -18.15M | -12.54M | -19.84M | -16.7M | -28.95M | -14.55M | -12.37M | -14.67M |
Selling & General & Admin | 12.71M | 19.07M | 16.01M | 12.13M | 11.36M | 10.69M | 9.55M | 7.38M | 7.36M | 7.46M | 11.81M | 12.46M | 15.59M | 13.02M | 14.98M | 12.13M | 13.13M | 13.23M |
Research & Development | 4.11M | 5.36M | 4.92M | 5.27M | 4.16M | 5.93M | 2.89M | 3.2M | 3.47M | 3.55M | 4.28M | 3.23M | 5.2M | 4.77M | 4.4M | 4.73M | 4.26M | 3.66M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 16.81M | 24.43M | 20.93M | 17.39M | 15.52M | 16.62M | 12.44M | 10.58M | 10.83M | 11M | 16.09M | 15.69M | 20.79M | 17.79M | 19.38M | 16.86M | 17.4M | 16.89M |
Interest Expense | 4.28M | 4.28M | 4.22M | 4.2M | 4.2M | 4.2M | 3.23M | 1.31M | 1.43M | 1.49M | 1.7M | 3.69M | 3.57M | 3.48M | 3.59M | 6.59M | 6.22M | 6.15M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 21.37M | 28.09M | 25.45M | 21.83M | 20.04M | 21.01M | 17.12M | 15.38M | 17.45M | 15.74M | 21.39M | 20.32M | 26.03M | 22.01M | 22.75M | 21.25M | 21.86M | 19.65M |
Income Tax Expense | n/a | n/a | -14K | n/a | n/a | n/a | 101K | -140K | 284K | -11.24M | 5.8M | 5K | 3.54M | 3.48M | n/a | -1K | n/a | -1K |
Shares Outstanding (Basic) | 99.33M | 95.5M | 91.2M | 91.08M | 90.91M | 73.61M | 68.53M | 64.68M | 57.35M | 55.63M | 54.39M | 53.42M | 45.28M | 41.31M | 40.39M | 39.22M | 37.07M | 35.56M |
Shares Outstanding (Diluted) | 99.33M | 95.5M | 91.2M | 91.08M | 90.91M | 73.61M | 68.53M | 64.68M | 57.35M | 73.79M | 54.39M | 53.42M | 45.46M | 41.47M | 40.39M | 39.22M | 37.07M | 35.56M |
EPS (Basic) | -0.14 | -0.24 | -0.19 | -0.13 | -0.03 | -0.17 | -0.12 | -0.03 | -0.1 | 0.35 | -0.33 | -0.23 | -0.44 | -0.4 | -0.72 | -0.37 | -0.33 | -0.41 |
EPS (Diluted) | -0.14 | -0.24 | -0.19 | -0.13 | -0.03 | -0.17 | -0.12 | -0.03 | -0.1 | 0.26 | -0.33 | -0.23 | -0.44 | -0.4 | -0.72 | -0.37 | -0.33 | -0.41 |
EBITDA | -9.13M | -15.76M | -12.7M | -7.15M | 1.66M | -8.42M | -4.31M | -606K | -3.79M | 9.88M | -10.25M | -8.25M | -12.06M | -9.01M | -24.63M | -7.23M | -5.4M | -7.77M |
EBIT | -9.27M | -18.65M | -12.85M | -7.31M | 1.45M | -8.63M | -4.78M | -863K | -4.08M | 9.55M | -10.65M | -8.85M | -12.73M | -9.74M | -25.36M | -7.97M | -6.14M | -8.53M |
Depreciation & Amortization | 140K | 2.89M | 147K | 159K | 205K | 207K | 467K | 257K | 289K | 325K | 397K | 596K | 667K | 727K | 731K | 737K | 740K | 756K |